Swiss Life slips after 9-month results
** Swiss Life SLHN.S shares fall 2.4%, analysts point to the insurer's solvency test ratio missing investor expectations, which already price in rising volumes
** "While no consensus was collected, we believe Swiss Solvency Test may have been below consensus expectations", J.P. Morgan says
** Swiss Life posts end-Sept SST ratio, a measure of required and available capital, at around 205%, down from 213% at end-December
** This may have more influence on the shares than "any positivity from the gross written premiums beat", JPM adds
** The company's premiums rise to 17.4 billion Swiss francs ($21 billion), which, JPM says, appears to be mainly due to a single large group life contract in Switzerland
** Rising volumes are already fully reflected in consensus expectations, Vontobel analysts say, adding they see no further near-term triggers for the stock
($1 = 0.8256 Swiss francs)